FDA Inspection 1006003 — Rhode Island Blood Center, A Division Of New York Blood Center, Inc. Woonsocket Donor Center

Rhode Island Blood Center, A Division Of New York Blood Center, Inc. Woonsocket Donor Center — FEI 3005078114

The FDA completed an inspection of Rhode Island Blood Center, A Division Of New York Blood Center, Inc. Woonsocket Donor Center on Mar 9, 2017 in Woonsocket, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 9, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Woonsocket, RI (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.